Literature DB >> 24074111

Condensed astatine: monatomic and metallic.

Andreas Hermann1, Roald Hoffmann, N W Ashcroft.   

Abstract

The condensed matter properties of the nominal terminating element of the halogen group with atomic number 85, astatine, are as yet unknown. In the intervening more than 70 years since its discovery significant advances have been made in substrate cooling and the other techniques necessary for the production of the element to the point where we might now enquire about the key properties astatine might have if it attained a condensed phase. This subject is addressed here using density functional theory and structural selection methods, with an accounting for relativistic physics that is essential. Condensed astatine is predicted to be quite different in fascinating ways from iodine, being already at 1 atm a metal, and monatomic at that, and possibly a superconductor (as is dense iodine).

Entities:  

Year:  2013        PMID: 24074111     DOI: 10.1103/PhysRevLett.111.116404

Source DB:  PubMed          Journal:  Phys Rev Lett        ISSN: 0031-9007            Impact factor:   9.161


  5 in total

Review 1.  Understanding Periodic and Non-periodic Chemistry in Periodic Tables.

Authors:  Changsu Cao; René E Vernon; W H Eugen Schwarz; Jun Li
Journal:  Front Chem       Date:  2021-01-06       Impact factor: 5.221

Review 2.  Realizing Clinical Trials with Astatine-211: The Chemistry Infrastructure.

Authors:  Sture Lindegren; Per Albertsson; Tom Bäck; Holger Jensen; Stig Palm; Emma Aneheim
Journal:  Cancer Biother Radiopharm       Date:  2020-02-20       Impact factor: 3.099

Review 3.  Copernicium: A Relativistic Noble Liquid.

Authors:  Jan-Michael Mewes; Odile R Smits; Georg Kresse; Peter Schwerdtfeger
Journal:  Angew Chem Int Ed Engl       Date:  2019-10-25       Impact factor: 15.336

Review 4.  The Halogen Bond.

Authors:  Gabriella Cavallo; Pierangelo Metrangolo; Roberto Milani; Tullio Pilati; Arri Priimagi; Giuseppe Resnati; Giancarlo Terraneo
Journal:  Chem Rev       Date:  2016-01-26       Impact factor: 60.622

5.  Targeted radionuclide therapy with astatine-211: Oxidative dehalogenation of astatobenzoate conjugates.

Authors:  David Teze; Dumitru-Claudiu Sergentu; Valentina Kalichuk; Jacques Barbet; David Deniaud; Nicolas Galland; Rémi Maurice; Gilles Montavon
Journal:  Sci Rep       Date:  2017-05-31       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.